Journal Article

The Toxicology Investigators Consortium Case Registry—the 2015 Experience

Wax, Paul M., Rhyee, Sean H., Weigand, Timothy, Brent, Jeffrey, Campleman, Sharan L., Farrugia, Lynn A., Ruha, Anne-Michelle

2016

نظرة عامة

The American College of Medical Toxicology established the Toxicology Investigators Consortium (ToxIC) Case Registry in 2010. The Registry contains all medical toxicology consultations performed at participating sites. The Registry has continued to grow since its inception, and as of December 31, 2015, contains 43,099 cases. This is the sixth annual report of the ToxIC Registry, summarizing the additional 8115 cases entered in 2015. Cases were identified by a query of the Registry for all cases entered between January 1 and December 31, 2015. Specific data reviewed for analysis included demographics (age, race, gender), source of consultation, reason for consultation, agents and agent classes involved in exposures, signs, symptoms, clinical findings, fatalities, and treatment. By the end of 2015, there were 50 active sites, consisting of 101 separate health-care facilities; 51.2 % of cases involved females. Adults between the ages of 19 and 65 made up the majority (64.2 %) of Registry cases. Caucasian race was the most commonly reported (55.6 %); 9.6 % of cases were identified as Hispanic ethnicity. Inpatient and emergency department referrals were by far the most common referral sources (92.9 %). Intentional pharmaceutical exposures remained the most frequent reason for consultation, making up 52.3 % of cases. Of these intentional pharmaceutical exposures, 69 % represented an attempt at self-harm, and 85.6 % of these were a suicide attempt. Nonopioid analgesics, sedative-hypnotics, and antidepressant agents were the most commonly reported agent classes in 2015. Almost one-third of Registry cases involved a diagnosed toxidrome (32.8 %), with a sedative-hypnotic toxidrome being the most frequently described. Significant vital sign abnormalities were recorded in 25.3 % of cases. There were 98 fatalities reported in the Registry (1.2 %). Adverse drug reactions were reported in 4.3 % of cases. Toxicological treatment was given in 65.3 % of cases, with 33.0 % receiving specific antidotal therapy. Exposure characteristics and trends overall were similar to prior years. While treatment interventions were required in the majority of cases, fatalities were rare.

• الناشر: Springer US,Springer Nature B.V
• موضوع: Abnormalities / Adolescent / Adult / Analgesics / Analgesics, Non-Narcotic - adverse effects / Analgesics, Non-Narcotic - chemistry / Analgesics, Non-Narcotic - poisoning / Anesthesia / Antidepressants / Antidepressive Agents - adverse effects / Antidepressive Agents - chemistry / Antidepressive Agents - poisoning / Antidotes - therapeutic use / Biomedical and Life Sciences / Biomedicine / Child / Consortia / Data collection / Demographics / Demography / Drug Overdose - drug therapy / Drug Overdose - mortality / Drug Overdose - therapy / Drug-Related Side Effects and Adverse Reactions - drug therapy / Drug-Related Side Effects and Adverse Reactions - mortality / Drug-Related Side Effects and Adverse Reactions - therapy / Emergency medical services / Ethnicity / Exposure / Fatalities / Health care facilities / Health services / Hospitals / Humans / Hypnotics / Hypnotics and Sedatives - adverse effects / Hypnotics and Sedatives - antagonists & inhibitors / Hypnotics and Sedatives - poisoning / Infant / Mental health / Minority & ethnic groups / Mortality / Pharmaceuticals / Pharmacology/Toxicology / Poisoning - drug therapy / Poisoning - mortality / Poisoning - therapy / Race / Referral and Consultation / Registries / Research Personnel / Self destructive behavior / Self-injury / Sentinel Surveillance / Side effects / Societies, Scientific / Special / Special Article / Substance abuse treatment / Suicide / Suicide, Attempted / Surveillance / Toxicology / Toxicology - manpower / Toxiferine - adverse effects / Toxiferine - antagonists & inhibitors / Toxiferine - poisoning / United States